Cytokinetics | CYTK - Market Capitalization

Stock Price
75.85
Daily Change
-2.79 -3.55%
Monthly
15.94%
Yearly
144.68%
Q2 Forecast
74.33

Cytokinetics reported $9.05B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Amgen USD 189.89B 13.64B Mar/2026
Arca Biopharma USD 1.47B 537M Dec/2025
Bayer EUR 37.69B 1.01B May/2026
Biogen USD 26.9B 1.09B Mar/2026
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cytokinetics USD 9.16B 975M May/2026
Eisai JPY 1.33T 22.44B May/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Exelixis USD 14.34B 3.44B May/2026
Geron USD 946M 9M May/2026
Halozyme Therapeutics USD 8.44B 781M May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026